Xencor (XNCR) Retained Earnings (2013 - 2026)
Xencor (XNCR) reported Retained Earnings of $27000.0 for Q1 2026, down 92.39% year-over-year from $355000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$796.0 million in Q4 2025.
Xencor (XNCR) Retained Earnings (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Retained Earnings data on file, last reported at $27000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at $27000.0, down 92.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $27000.0 (down 92.39% YoY), and the FY2025 annual result was -$796.0 million, down 119954.15% from the prior year.
- Retained Earnings rose to $27000.0 in Q1 2026 per XNCR's latest filing, from -$796.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.8 million in Q3 2024 and troughed at -$796.0 million in Q4 2025.
- A 5-year average of -$232.3 million and a median of -$7.1 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 1956466.67% in 2022, then soared 330.52% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$7.0 million in 2022, then surged by 118.57% to $1.3 million in 2023, then sank by 151.36% to -$663000.0 in 2024, then plunged by 119954.15% to -$796.0 million in 2025, then jumped by 100.0% to $27000.0 in 2026.
- Business Quant data shows XNCR's Retained Earnings at $27000.0 in Q1 2026, -$796.0 million in Q4 2025, and -$789.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | -795.96 Mn |
| Sep 30, 2025 | -789.31 Mn |
| Jun 30, 2025 | -783.28 Mn |
| Mar 31, 2025 | 355,000.00 |
| Dec 31, 2024 | -663,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | -652,000.00 |
| Mar 31, 2024 | -154,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | -445.27 Mn |
| Jun 30, 2023 | -421.00 Mn |
| Mar 31, 2023 | -399.05 Mn |
| Dec 31, 2022 | -6.95 Mn |
| Sep 30, 2022 | -9.88 Mn |
| Jun 30, 2022 | -293.49 Mn |
| Mar 31, 2022 | -7.12 Mn |
| Dec 31, 2021 | -1.51 Mn |
| Sep 30, 2021 | -74,000.00 |
| Jun 30, 2021 | -15,000.00 |